ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 50 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $64,000 | -80.2% | 11,199 | -53.1% | 0.00% | -83.3% |
| Q3 2018 | $324,000 | -44.6% | 23,874 | -51.6% | 0.01% | -45.5% |
| Q2 2018 | $585,000 | +2.8% | 49,308 | -2.7% | 0.01% | -8.3% |
| Q1 2018 | $569,000 | +63.5% | 50,655 | -2.7% | 0.01% | +71.4% |
| Q4 2017 | $348,000 | -22.0% | 52,082 | -4.5% | 0.01% | -22.2% |
| Q3 2017 | $446,000 | +177.0% | 54,511 | +51.4% | 0.01% | +125.0% |
| Q2 2017 | $161,000 | -21.5% | 36,011 | -3.6% | 0.00% | -20.0% |
| Q1 2017 | $205,000 | +2462.5% | 37,337 | +3633.7% | 0.01% | – |
| Q2 2016 | $8,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $12,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $5,165,000 | 4.93% |
| Long Focus Capital Management, LLC | 4,429,491 | $9,125,000 | 1.17% |
| Endurant Capital Management LP | 2,160,890 | $4,451,000 | 1.17% |
| NEA Management Company, LLC | 17,082,611 | $35,190,000 | 1.02% |
| Matrix Capital Management Company, LP | 38,974,185 | $80,287,000 | 0.96% |
| Key Client Fiduciary Advisors, LLC | 420,447 | $866,000 | 0.68% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $185,000 | 0.20% |
| DAFNA Capital Management LLC | 351,064 | $723,000 | 0.19% |
| PFM Health Sciences, LP | 2,374,674 | $4,892,000 | 0.18% |
| Rock Springs Capital Management LP | 2,297,194 | $4,732,000 | 0.12% |